Superficial Thrombophlebitis in Ipsilateral Breast After Covid-19 Vaccination

Authors

Shima Aran
Orest O Kayder
Teena Chopra
Hani Abujudeh

Publication Date

8-1-2022

Journal

Radiology Case Reports

Abstract

On December 2020, the US Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report development of superficial thrombophlebitis in the ipsilateral breast of a 43-year-old female 7 days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Given that this is the first case of superficial thrombophlebitis in the breast shortly after mRNA vaccination for COVID-19 reported to our knowledge, we suggest that this may be a rare vaccine-related event.

Keywords

COVID, COVID19 vaccine, Mondor’s disease, mRNA vaccination, superficial thrombophlebitis.